Fig. 2From: Methotrexate improves endothelial function in early rheumatoid arthritis patients after 3 months of treatmentCorrelation of endothelial dysfunction biomarkers changes with disease activity. The variation (Δ) of circulating Tang cells (A), CD28 + Tang cells (B), sVCAM-1 (C), EMPs (D), platelet CD40L (E) and EPCs (F) after 3 months of MTX treatment does not correlate with the change in disease activity according to DAS28-CRPBack to article page